Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulmicort Turbuhaler vs Respules in Japanese Asthma Patients
NCT00855959Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2009
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of budesonide in asthma (2 arms), sponsored by AstraZeneca. Primary endpoint: Morning Peak Expiratory Flow at 6 weeks. Started Feb 2009; status: completed.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00855959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00855959.